Heuristically-driven platform and method for hiring based on previously-supported jobs

    公开(公告)号:US09946993B2

    公开(公告)日:2018-04-17

    申请号:US13282176

    申请日:2011-10-26

    CPC classification number: G06Q10/1053

    Abstract: A heuristically-driven platform and method for hiring based on previously-supported jobs and collected metrics solves the problem of efficiently connecting hiring agents and suitable job candidates. A portal application includes an inventory of successful placements and successful listings, allowing hiring agents to build job searches against a database of historical jobs. Leveraging the portal's inventory of placements and listings, the hiring agent may build a listing and design a candidate search based on previous listings, search venues for the same job type and metrics collected against each. An embodiment may provide the hiring agent a listing of the hiring agent's jobs, a list of applicants for each listed job and the detail for each applicant. The platform monitors applicant flow, online interviews, and site usage analytics for each position, suggesting alternatives and course corrections to the hiring agent if the performance of the job search is sub-par based on benchmarks.

    Interactive safe for vehicles
    4.
    发明申请
    Interactive safe for vehicles 审中-公开
    互动安全的车辆

    公开(公告)号:US20080196637A1

    公开(公告)日:2008-08-21

    申请号:US12009748

    申请日:2008-01-22

    CPC classification number: E05G1/005

    Abstract: An interactive safe that can be permanently attached to a vehicle is any location; it is capable of holding different items, designed in various shapes and sizes, customizable to interact with car manufacturers, and can be placed in various locations in a vehicle; the built-in electronic system may be connected to the vehicle's computer system, alarm system, or power source.

    Abstract translation: 可以永久性地连接到车辆的交互式保险箱是任何位置; 它能够保持不同形状和尺寸的不同物品,可定制与汽车制造商交互,并且可以放置在车辆的各个位置; 内置的电子系统可以连接到车辆的计算机系统,报警系统或电源。

    ANIMAL TAGS AND METHOD OF MANUFACTURE
    7.
    发明申请
    ANIMAL TAGS AND METHOD OF MANUFACTURE 审中-公开
    动物标签和制造方法

    公开(公告)号:US20110041367A1

    公开(公告)日:2011-02-24

    申请号:US12990505

    申请日:2009-04-27

    CPC classification number: G09F3/12 A01K11/001 A01K11/003 Y10T29/49826

    Abstract: An animal tag includes a flag (11) of substantially flexible material about which is secured a substantially rigid assembly (14) including a flanged member (15), a cap (17), and an insert (18) which assists the retention of the head of a male tag (not shown) within the cap (17). In another embodiment the tag is formed as a strip of indeterminate length of the flexible material. The aperture (19) may also be omitted and formed during use of the tag, by the head of the male tag. The substantially rigid assembly (14) may provide part of a male tag or part of a female tag as shown.

    Abstract translation: 动物标签包括基本上柔性材料的标志(11),围绕所述标志(11)固定有包括凸缘构件(15),盖(17)和插入件(18)的基本上刚性的组件(14),所述凸缘有助于保持 帽(17)内的公标签(未示出)的头部。 在另一个实施例中,标签形成为柔性材料的不确定长度的条带。 通过男性标签的头部,也可以在使用标签期间省略并形成孔(19)。 如图所示,基本上刚性的组件(14)可以提供男性标签或女性标签的一部分的一部分。

    Urogenital or anorectal transmucosal vaccine delivery system
    9.
    发明申请
    Urogenital or anorectal transmucosal vaccine delivery system 审中-公开
    泌尿生殖或肛门直肠经粘膜疫苗递送系统

    公开(公告)号:US20070082010A1

    公开(公告)日:2007-04-12

    申请号:US11580258

    申请日:2006-10-12

    Abstract: The invention is directed to a suppository based vaccine delivery system for immunizing against urogenital and anorectally transmitted infectious disease in humans and animals and a method for treating the same. More particularly, this invention is directed to a suppository based vaccine delivery system for the prophylaxis against or treatment of urogenital or anorectal transmitted infectious diseases, such as from viral or microbial pathogens. The suppository based delivery system comprises vaccine and/or vaccine adjuvant(s) comprised of whole or fractionated viral or other microbial pathogens, or their purified cellular constituents, whether native, mutated, synthetic, cloned or recombinantly expressed, that consists of nucleic acids, proteins, lipids or other antigenic determinants capable of producing humoral or cellular-mediated immunity in humans or animals; and a polyethylene glycol base; wherein the suppository is adapted to be inserted into a bodily orifice of a human or animal so as to allow the suppository to be in contact with tissue of the bodily orifice to facilitate transfer of vaccine or vaccine adjuvant(s) material therethrough.

    Abstract translation: 本发明涉及一种用于在人类和动物中免疫泌尿生殖和肛门直肠传播的传染病的基于栓剂的疫苗递送系统及其治疗方法。 更具体地,本发明涉及一种基于栓剂的疫苗递送系统,用于预防或治疗泌尿生殖或肛门直肠传播的传染病,例如病毒或微生物病原体。 基于栓剂的递送系统包括由全部或分馏的病毒或其他微生物病原体组成的疫苗和/或疫苗佐剂,或其纯化的细胞成分,无论是天然的,突变的,合成的,克隆的或重组表达的,由核酸组成, 能够在人或动物中产生体液或细胞介导的免疫的蛋白质,脂质或其它抗原决定簇; 和聚乙二醇碱; 其中栓剂适于插入人或动物的身体孔中,以便使栓剂与身体孔的组织接触以促进疫苗或疫苗佐剂材料通过其传送。

    Urogenital or anorectal transmucosal vaccine delivery system

    公开(公告)号:US07135191B2

    公开(公告)日:2006-11-14

    申请号:US09516078

    申请日:2000-03-01

    Abstract: The invention is directed to a suppository based vaccine delivery system for immunizing against urogenital and anorectally transmitted infectious disease in humans and animals and a method for treating the same. More particularly, this invention is directed to a suppository based vaccine delivery system for the prophylaxis against or treatment of urogenital or anorectal transmitted infectious diseases, such as from viral or microbial pathogens. The suppository based delivery system comprises vaccine and/or vaccine adjuvant(s) comprised of whole or fractionated viral or other microbial pathogens, or their purified cellular constituents, whether native, mutated, synthetic, cloned or recombinantly expressed, that consists of nucleic acids, proteins, lipids or other antigenic determinants capable of producing humoral or cellular-mediated immunity in humans or animals; and a polyethylene glycol base; wherein the suppository is adapted to be inserted into a bodily orifice of a human or animal so as to allow the suppository to be in contact with tissue of the bodily orifice to facilitate transfer of vaccine or vaccine adjuvant(s) material therethrough.

Patent Agency Ranking